No Data
No Data
Humanwell Healthcare Registers Triglyceride-Lowering Drug in China
Humanwell Healthcare (600079.SH): Pharmaceutical registration certificate obtained for Omega-3 ethyl ester 90 capsules.
Humanwell Healthcare (600079.SH) announced that its wholly-owned subsidiary, Wuhan Puke Pharmaceutical Co., Ltd. (referred to as "Wuhan Puke"), recently received the Drug Registration Certificate issued by the National Medical Products Administration for the omega-3 fatty acid ethyl ester 90 soft capsule. The omega-3 fatty acid ethyl ester 90 soft capsule is mainly used to lower triglyceride (TG) levels in adult patients with severe hypertriglyceridemia (≥500mg/dL) on the basis of controlled diet.
Humanwell Healthcare's Unit Gets GMP Certificate From UK Regulator
Humanwell Healthcare (600079.SH): Its subsidiary passes the UK GMP compliance inspection.
On August 5, Glonhoy announced that Humanwell Healthcare (600079.SH), a holding subsidiary, recently received a GMP certificate with the number "UKGMP48442InspGMP48442/33381169-0003" issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA). The production line involved in this certification is the final sterilization small volume injection production line of Humanwell in Yichang's global headquarters base at No. 517 Donglin Road in Yichang City, with an annual designed production capacity of 0.5 billion small volume injections. It obtained the GMP certification of MHRA in October 2023 for pharmaceutical production.
Earnings Working Against Humanwell Healthcare (Group) Co.,Ltd.'s (SHSE:600079) Share Price
Humanwell Healthcare Semi-Annual Report for 2024
No Data